Prospective randomized comparison of 1-week RBC triple therapy versus 1-week PPI triple therapy for H-pylori-related duodenal ulcers.

被引:0
|
作者
Sung, JY
Leung, WK
Ling, TKW
Yung, MY
Chan, KL
Lee, YT
Chung, SCS
Cheng, AFB
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Sha Tin 100083, Hong Kong
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Sha Tin 100083, Hong Kong
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Sha Tin 100083, Hong Kong
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
G1216
引用
收藏
页码:A296 / A297
页数:2
相关论文
共 50 条
  • [1] 2-week is better than 1-week triple therapy for H. pylori eradication
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (4): : 180 - 180
  • [2] Randomized comparison of 1-week and 2-week bismuth subsalicylate-based triple therapy for the treatment of H-pylori.
    Yang, R
    Hamamoto, R
    Laine, L
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A302 - A302
  • [3] Italian omeprazole triple therapy - A 1-week regimen
    Bazzoli, F
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 118 - 118
  • [4] Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients
    Goh, KL
    Parasakthi, N
    Cheah, PL
    Ranjeev, CK
    Rosmawati, M
    Tan, YM
    Chin, SC
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (08) : 910 - 914
  • [5] Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection
    Savarino, V
    Vigneri, S
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (09) : 1251 - 1251
  • [6] Effect of 1-week triple therapy for Helicobacter pylori infection with lansoprazole or ranitidine and clarithromycin and metronidazole
    Kihira, K
    Kimura, K
    Satoh, K
    Takimoto, T
    Saifuku, K
    Taniguchi, Y
    Kojima, T
    Tokumaru, K
    Yamamoto, H
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A154 - A154
  • [7] One-week ranitidine bismuth citrate (RBC) triple therapy versus proton-pump inhibitor (PPI) triple therapy for the treatment of H-pylori-associated duodenal ulcers
    Sung, JY
    Leung, WK
    Ling, TKW
    Yung, MY
    Chan, KL
    Lee, YT
    Chung, SCS
    Cheng, AFB
    [J]. GUT, 1997, 41 : A51 - A52
  • [8] Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication
    Scott, BB
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (03) : 277 - 279
  • [9] Two-week Triple Therapy has a Higher Helicobacter pylori Eradication Rate Than 1-week Therapy: A Single-center Randomized Study
    Wang, Jiaofeng
    Zhang, Gansheng
    Hu, Xiaona
    Liu, Ye
    Bao, Zhijun
    Huang, Yiqin
    [J]. SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06): : 355 - 359
  • [10] Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy
    Huang, AH
    Sheu, BS
    Yang, HB
    Huang, CC
    Wu, JJ
    Lin, XZ
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (09) : 704 - 709